Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 11, 2009Annals of Neurology

Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain‐Barré syndrome

View Full Paper
Ask AI
Bookmark
Share

Authors

KKKrista KuitwaardErasmus MCJGJenny de GelderErasmus MCATAnne P. Tio‐GillenErasmus MC

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kuitwaard et al. (2009) studied this question.

synapsesocial.com/papers/6a77a3534fe2e6ffd8ecd3f4https://doi.org/10.1002/ana.21737
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Intravenous Immune Globulin Therapy for Neurologic Diseases1997 · 228 citations
  2. 2Diagnostic considerations in Guillain-Barr� syndrome1981 · 330 citations
  3. 3Metabolism of Immunoglobulins2015 · 726 citations
  4. 4Immunotherapy for Guillain-Barre syndrome: a systematic review2007 · 465 citations
  5. 5Accelerated autoantibody clearance by intravenous immunoglobulin therapy: studies in experimental models to determine the magnitude and time course of the effect2001 · 99 citations